LIGAND PHARMACEUTICALS INCORPORATED Increase Decrease In Operating Lease Liability
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Increase Decrease In Operating Lease Liability of $1.60 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2025-02-28
- LIGAND PHARMACEUTICALS INCORPORATED increase decrease in operating lease liability for the quarter ending 2024-09-30 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED increase decrease in operating lease liability for the quarter ending 2024-06-30 was $1.60M.
- LIGAND PHARMACEUTICALS INCORPORATED increase decrease in operating lease liability for the quarter ending 2023-12-31 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED increase decrease in operating lease liability for fiscal 2023 was $1.10M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $1.60M derived: sum of 2 quarters · filed 2024-11-08 | $1.60M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $1.60M 10-Q · filed 2024-08-07 | $1.60M 10-Q · filed 2024-08-07 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $1.10M 10-K · filed 2025-02-28 | ||
| 2023-09-30 | $1.10M 10-Q · filed 2023-11-09 | |||
| 2021-09-30 | $6.12M 10-Q · filed 2021-11-09 | |||
| 2020-09-30 | -$226.00K 10-Q · filed 2021-11-09 |